GlassScriptPhysician profile
Laura R Peter
NPI 1992148035
$2,571.29
in general payments reported to CMS, 2019-2025
24 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $24.95 · 2021: $433 · 2022: $444 · 2023: $681 · 2024: $378 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $446.04 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $406.74 | 2021-2025 | |
| Hologic Sales and Service, LLC | $339.74 | 2021-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Pfizer INC. | $157.47 | 2019-2023 | |
| Astellas Pharma US INC | $153.01 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $141.50 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $130.28 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $119.56 | 2022-2025 | Jada System, Nexplanon |
| Evofem Biosciences, INC. | $100.83 | 2021-2023 | Phexxi |
| Exact Sciences Corporation | $93.32 | 2023-2024 | Cologuard Collection Kit |
| Exeltis, USA INC. | $81.74 | 2019-2023 | Slynd |
| Therapeuticsmd, INC. | $74.84 | 2019-2021 | |
| Shield Therapeutics INC | $58.05 | 2023-2024 | Accrufer |
| Novo Nordisk INC | $51.71 | 2022 | |
| Coopersurgical, INC. | $51.09 | 2021-2024 | Summit Doppler, Paragard T 380a |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $25.36 | 2022 | |
| Dexcom, INC. | $24.10 | 2025 | Dexcom G6 Transmitter |
| Applied Medical Resources Corporation | $19.25 | 2019 | |
| Avion Pharmaceuticals | $19.14 | 2022 | |
| Conmed Corporation | $18.20 | 2023 | Airseal, Vcare |
| Myovant Sciences INC. | $17.09 | 2022 | |
| Channel Medsystems, INC. | $14.79 | 2023 | |
| Millicent US INC | $14.53 | 2024 | Femring, Intrarosa |
| Takeda Pharmaceuticals U.S.A., INC. | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Peter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.